Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / internal-memo-deal-summary-key-issues.docx
internal-memo-deal-summary-key-issues.docx
Parties
HARKNESS LLP
Genome Dx Therapeutics Inc
Pinnacle Venture Lending Corp
Pacific Fiduciary Services Inc
Calloway LLP
Delaware Inc
Celanova Biosciences Inc
Helix Pathway Inc
Dates
February 12, 2026
February 10, 2026
February 14, 2026
March 6, 2027
April 1, 2026
December 31, 2025
February 24, 2026
Amounts
$15,000,000
$10,000,000
$5,000,000
$42,000,000
$2.18
$105,730,000
$3,200,000
$2.8
$1.4
$900,000
Obligations
This filing is necessary because, under federal law, a security interest in issued patents must be recorded with the USPTO to achieve perfection, and recording at the USPTO provides additional constructive notice to third parties
Financial Covenants The Bridge Loan Agreement will include two financial covenants, as set forth below: Minimum Cash Covenant: GenomeDx is required to maintain unrestricted cash and cash equivalents of not less than $3,000,000 at all times
GenomeDx shall have delivered certificates of insurance evidencing (i) directors and officers liability insurance maintained with Sentinel Specialty Insurance Co
The certificates must show that the policies are in full force and effect and must name the Administrative Agent and the Collateral Agent as additional insureds or loss payees, as applicable
GenomeDx shall have paid (i) the commitment fee of $150,000 (Pinnacle: $100,000; Cobalt: $50,000) and (ii) the administrative agent fee of $25,000 to Pinnacle
" The definition of Ridgeline Priority Collateral must be narrowly tailored to the specific equipment schedule under the existing Ridgeline Facility